Effect of the Combined Probiotics on Inhibiting Pathogenic Escherichia coli Prolification

Article Preview

Abstract:

The study on the combined probiotics to replace antibiotics becomes more and more important because the by-effects and appearance of “superbug” from abuse of antibiotics in human life and animal production. In order to get the effective combined probiotics for replacing antibiotics and inhibiting pathogenic Escherichia coli (E. coli) prolification, 3 strains of Bacillus subtilis (B. subtilis, named as B1, B2 and B3) were used to determine the pre-combination with experimental design (3 factors×4 levels), and then the pre-combination of B. subtilis was combined with Lactobacillus casei (L. casei) and Hansenula anomala (H. anomala) to achieve the most effective combined probiotics with the same design. The results indicated that the pre-combination ratio of B1, B2 and B3 was 0:1:1, and the most effective combination ratios of the pre-combination, L. casei and H. anomala were 0:1:1, 1:3:0, 2:2:3, 2:3:2, respectively (P<0.05). In addition, the incubating groups containing L. casei had better effect on inhibiting E. coli prolification than those without Lactobacillus, indicating that Lactobacillus had the best effect on inhibiting E. coli prolification, compared with other bacteria.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 343-344)

Pages:

802-808

Citation:

Online since:

September 2011

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] D. Ferber, Infectious disease. From pigs to people: the emergence of a new superbug. Science[J], 2010, 329(5995), 1010-1011.

DOI: 10.1126/science.329.5995.1010

Google Scholar

[2] P. C. Webster. Global action urged in response to new breed of drug-resistant bacteria[J], Canadian Medical Association Journal. 2010, 182(15). 1602-1603.

DOI: 10.1503/cmaj.109-3675

Google Scholar

[3] J. A. Patterson, and K. M. Burkholder, Application of prebiotics and probiotics in poultry production[J], Poult. Sci., 2003, 82, 627–631.

DOI: 10.1093/ps/82.4.627

Google Scholar

[4] G. Reid, and R. Friendship, Alternatives to antibiotic use, probiotics for the gut[J], Anim. Biotechnol., 2002, 13, 97–112.

Google Scholar

[5] S. Salminen, G. Gibson, M. C. Bouley, E. Isolauri, M. C. Boutron-Rualt, and J. Cummings et al. Gastrointestinal physiology and function: The role of prebiotics and probiotics[J], Br. J. Nutr., 1998, 80 (Suppl 1), 147-171.

DOI: 10.1079/bjn19980108

Google Scholar

[6] S. C. Kyriakis, I. Georgoulakis, A. Spais, C. Alexopoulos, C. C. Miliotis, and S. K. Kritas, Evaluation of Toyocerin, a probiotic containing Bacillus toyoi spores on health status and productivity of weaned, growing and finishing pigs[J], Asian-Aust. J. Anim. Sci., 2003, 16(9), 1326-1331.

DOI: 10.5713/ajas.2003.1326

Google Scholar

[7] Guo Xiaohua, Zhao Zhidan, The advance of application and acting mechanisms of Bacillus subtilis[J], China Animal Science and Veterinary Medicine, 2010, 37(7), 212-214 (Ch).

Google Scholar

[8] Huang Xuequan, Effect of Bacillus subtilis addition on piglet production performance[J], China Animal Science and Veterinary Medicine, 2010, 37(2), 27-31(Ch).

Google Scholar

[9] Zhang Huihua, Cao Yongchang, Bi Yingzuo, The experiments of 6 strains of lactic acid bacteria for inhibiting bacterium growth in vitro[J], Chinese Journal of Veterinary Medicine, 2001, 37(7), 8-10(Ch).

Google Scholar

[10] Kuang Zheshi, Zhang Linghua, Tian Xingshan, The effect of compound probiotics on inhibiting pathogenic bacteria in piglet gut[J], Guangdong Agricultural Sciences, 2005, 2, 72-73(Ch).

Google Scholar

[11] A. Blomberg, and P. L. Comcay, Inhibition of Escherichia coli K88 to piglet ileal musus by Lactobacillus spp[J], Appl. Environ. Microbi. ,1993, 1, 34-39.

DOI: 10.1128/aem.59.1.34-39.1993

Google Scholar

[12] T. Asahara, K. Shimizu, and K. Nomoto K, Probiotic bifidobacteria protect mice from lethal infect ion with Shiga toxin producing Escherichia coli O157: H7[J], Infec. Immun., 2004, 72(4), 2240-2247.

DOI: 10.1128/iai.72.4.2240-2247.2004

Google Scholar

[13] Tiao Zhaofang, Chang Weishan, Tang Kexin, The selection of lactic acid bacteria for bactericin secretion and analysis of its inhibiting bacterium functions in vitro[J], Chinese Journal of Microecology, 2003, 15(2), 87-88(Ch).

Google Scholar